tiprankstipranks
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
US Market
Holding LENZ?
Track your performance easily

LENZ Therapeutics (LENZ) Financial Statements

150 Followers

LENZ Therapeutics Financial Overview

LENZ Therapeutics's market cap is currently ―. The company's EPS TTM is $-7.07; its P/E ratio is -4.80; LENZ Therapeutics is scheduled to report earnings on May 7, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -10.21M$ -10.25M$ -16.09M$ -22.92M$ -18.88M
EBITDA$ -10.21M$ -9.96M$ -16.08M$ -17.81M$ -18.88M
Net Income Common Stockholders$ -10.21M$ -10.25M$ -16.65M$ -34.18M$ -18.88M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 217.11M$ 196.11M$ 213.28M$ 184.26M$ 233.99M
Total Assets$ 224.01M$ 202.64M$ 217.32M$ 188.46M$ 266.23M
Total Debt$ 953.00K$ 1.05M$ 156.00K$ 362.00K$ 53.10M
Net Debt$ -216.15M$ -195.06M$ -213.12M$ -183.90M$ -180.89M
Total Liabilities$ 8.73M$ 9.72M$ 19.16M$ 4.87M$ 62.21M
Stockholders Equity$ 215.28M$ 192.92M$ 198.17M$ 183.58M$ 204.02M
Cash Flow-
Free Cash Flow$ -10.77M$ -15.93M$ -23.94M$ -45.25M$ -13.09M
Operating Cash Flow$ -10.58M$ -15.79M$ -23.94M$ -45.88M$ -13.09M
Investing Cash Flow$ -62.23M$ -98.39M$ 18.00M$ 47.08M$ -17.91M
Financing Cash Flow$ 29.82M$ -2.14M$ 171.27M$ 66.00K$ -568.00K
Currency in USD

LENZ Therapeutics Earnings and Revenue History

LENZ Therapeutics Debt to Assets

LENZ Therapeutics Cash Flow

LENZ Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis